GlassScriptPhysician profile
Sidra Kalsoom
NPI 1275103186
$7,099.21
in general payments reported to CMS, 2019-2025
20 companies · $5,827 in 2025
The $5,827 reported for 2025 was more than what 98% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $133 · 2022: $162 · 2023: $13.92 · 2024: $964 · 2025: $5,827.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,426 · Food and Beverage: $2,282 · Education: $96.23.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,426.24 |
| Food and Beverage | $2,281.85 |
| Education | $96.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,874.90 | 2025 | Gallant, Ensite, Perclose Prostyle |
| Atricure, INC. | $1,732.24 | 2024-2025 | Synergy Ablation System, Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Medtronic, INC. | $1,446.72 | 2025 | Advisa Dr Mri Surescan, Micra |
| Astrazeneca Pharmaceuticals LP | $245.35 | 2021-2022 | |
| Abiomed | $146.66 | 2024-2025 | Impella |
| Novo Nordisk INC | $107.97 | 2023-2024 | |
| Edwards Lifesciences Corporation | $97.04 | 2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Bayer Healthcare Pharmaceuticals INC. | $86.53 | 2025 | |
| Bridgebio Pharma, INC. | $76.48 | 2025 | Attruby |
| Abbvie INC. | $61.74 | 2022-2024 | |
| Chiesi USA, INC. | $45.44 | 2025 | Kengreal |
| Janssen Biotech, INC. | $33.79 | 2024 | Tremfya |
| Alnylam Pharmaceuticals INC. | $24.84 | 2025 | Onpattro |
| Philips North America LLC | $21.78 | 2025 | Ecc Solutions |
| Aimmune Therapeutics, INC. | $21.07 | 2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $19.53 | 2024 | Taltz |
| Ani Pharmaceuticals, INC. | $16.21 | 2024 | Purified Cortrophin Gel |
| Sandoz INC. | $14.83 | 2024 | Hyrimoz |
| Organon LLC | $13.72 | 2024 | |
| Alexion Pharmaceuticals, INC. | $12.37 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sidra Kalsoom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.